Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.7 EUR | -4.90% | -6.31% | -10.06% |
04-24 | IMCD's Spanish Unit to Buy Cobapharma | MT |
03-27 | IMCD's Benelux Arm to Purchase Gova Ingredients | MT |
Sales 2024 * | 4.73B 5.06B 405B | Sales 2025 * | 5.07B 5.42B 434B | Capitalization | 8.07B 8.62B 691B |
---|---|---|---|---|---|
Net income 2024 * | 305M 326M 26.12B | Net income 2025 * | 332M 355M 28.43B | EV / Sales 2024 * | 1.95 x |
Net Debt 2024 * | 1.15B 1.23B 98.26B | Net Debt 2025 * | 981M 1.05B 83.97B | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
26.7
x | P/E ratio 2025 * |
24.9
x | Employees | - |
Yield 2024 * |
1.6% | Yield 2025 * |
1.68% | Free-Float | 98.13% |
Latest transcript on IMCD N.V.
1 day | -4.90% | ||
1 week | -6.31% | ||
Current month | -13.25% | ||
1 month | -13.20% | ||
3 months | +0.14% | ||
6 months | +28.24% | ||
Current year | -10.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 29/06/20 | |
Hans Kooijmans
DFI | Director of Finance/CFO | 63 | 28/02/11 |
Marcus Jordan
COO | Chief Operating Officer | 50 | 31/12/97 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 08/05/18 | |
Amy Motto
BRD | Director/Board Member | 52 | 29/06/20 |
Willem Eelman
BRD | Director/Board Member | 60 | 01/05/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.06% | 303 M€ | +12.60% | ||
0.37% | 18 M€ | +3.79% | - | |
0.21% | 2 M€ | +7.72% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 141.7 | -4.90% | 511,882 |
25/04/24 | 149 | -1.65% | 161,220 |
24/04/24 | 151.5 | -1.85% | 152,814 |
23/04/24 | 154.4 | +1.88% | 115,921 |
22/04/24 | 151.5 | +0.17% | 77,364 |
Real-time Euronext Amsterdam, April 26, 2024 at 04:35 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.06% | 8.61B | |
+25.96% | 1.01B | |
+8.23% | 173M | |
+36.99% | 143M | |
+4.24% | 115M | |
-4.88% | 99.64M | |
+7.15% | 87.9M |
- Stock Market
- Equities
- IMCD Stock